David G. Hoel

Title
InstitutionMedical University of South Carolina
DepartmentPublic Health Sciences
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Brooks AL, Hoel D, Glines WM. Radiobiology of Select Radionuclides in Hanford Site Tank Waste. Health Phys. 2022 08 01; 123(2):99-115. PMID: 35506883.
      Citations:    
    2. Alfredsson L, Armstrong BK, Butterfield DA, Chowdhury R, de Gruijl FR, Feelisch M, Garland CF, Hart PH, Hoel DG, Jacobsen R, Lindqvist PG, Llewellyn DJ, Tiemeier H, Weller RB, Young AR. Insufficient Sun Exposure Has Become a Real Public Health Problem. Int J Environ Res Public Health. 2020 07 13; 17(14). PMID: 32668607.
      Citations:    
    3. Priest ND, Dauer LT, Hoel DG. Administration of lower doses of radium-224 to ankylosing spondylitis patients results in no evidence of significant overall detriment. PLoS One. 2020; 15(4):e0232597. PMID: 32353063.
      Citations:    
    4. Hoel DG, de Gruijl FR. Sun Exposure Public Health Directives. Int J Environ Res Public Health. 2018 12 10; 15(12). PMID: 30544646.
      Citations:    
    5. Hoel DG. Quantitative Risk Assessment in the 1970s: A Personal Remembrance. Dose Response. 2018 Oct-Dec; 16(4):1559325818803230. PMID: 30302069.
      Citations:    
    6. Hoel DG. Nuclear epidemiologic studies and the estimation of DREF. Int J Radiat Biol. 2018 04; 94(4):307-314. PMID: 29400635.
      Citations:    
    7. Dauer LT, Ainsbury EA, Dynlacht J, Hoel D, Klein BEK, Mayer D, Prescott CR, Thornton RH, Vano E, Woloschak GE, Flannery CM, Goldstein LE, Hamada N, Tran PK, Grissom MP, Blakely EA. Guidance on radiation dose limits for the lens of the eye: overview of the recommendations in NCRP Commentary No. 26. Int J Radiat Biol. 2017 10; 93(10):1015-1023. PMID: 28346025.
      Citations:    
    8. Hoel DG, Carnes BA. Cardiovascular effects of fission neutron or 60Co ? exposure in the B6CF1 mouse. Int J Radiat Biol. 2017 06; 93(6):563-568. PMID: 28112567.
      Citations:    
    9. Hoel DG. Commercial tanning salons and melanoma risk. Dermatoendocrinol. 2017; 9(1):e1270485. PMID: 28405266.
      Citations:    
    10. Hoel DG, Berwick M, de Gruijl FR, Holick MF. The risks and benefits of sun exposure 2016. Dermatoendocrinol. 2016 Jan-Dec; 8(1):e1248325. PMID: 27942349.
      Citations:    
    11. Brooks AL, Hoel DG, Preston RJ. The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation. Int J Radiat Biol. 2016 08; 92(8):405-26. PMID: 27266588.
      Citations:    
    12. Soffritti M, Tibaldi E, Padovani M, Hoel DG, Giuliani L, Bua L, Lauriola M, Falcioni L, Manservigi M, Manservisi F, Belpoggi F. Synergism between sinusoidal-50?Hz magnetic field and formaldehyde in triggering carcinogenic effects in male Sprague-Dawley rats. Am J Ind Med. 2016 07; 59(7):509-21. PMID: 27219869.
      Citations:    
    13. Soffritti M, Tibaldi E, Padovani M, Hoel DG, Giuliani L, Bua L, Lauriola M, Falcioni L, Manservigi M, Manservisi F, Panzacchi S, Belpoggi F. Life-span exposure to sinusoidal-50?Hz magnetic field and acute low-dose ? radiation induce carcinogenic effects in Sprague-Dawley rats. Int J Radiat Biol. 2016; 92(4):202-14. PMID: 26894944.
      Citations:    
    14. Dauer LT, Ainsbury EA, Dynlacht J, Hoel D, Klein BE, Mayer D, Prescott CR, Thornton RH, Vano E, Woloschak GE, Flannery CM, Goldstein LE, Hamada N, Tran PK, Grissom MP, Blakely EA. Status of NCRP Scientific Committee 1-23 Commentary on Guidance on Radiation Dose Limits for the Lens of the Eye. Health Phys. 2016 Feb; 110(2):182-4. PMID: 26717175.
      Citations:    
    15. Hoel DG. Comments on the DDREF estimate of the BEIR VII Committee. Health Phys. 2015 Mar; 108(3):351-6. PMID: 25627947.
      Citations:    
    16. Moolgavkar SH, Anderson EL, Chang ET, Lau EC, Turnham P, Hoel DG. A review and critique of U.S. EPA's risk assessments for asbestos. Crit Rev Toxicol. 2014 Jul; 44(6):499-522. PMID: 24806876.
      Citations:    
    17. Priest ND, Hoel D, Uralbekov B, Baizakova DO, Burkitbayev M. Childhood exposures to Rn-222 and background gamma radiation in the uranium provinces of south Kazakhstan and northern Kyrgyzstan. J Environ Radioact. 2013 Sep; 123:99-103. PMID: 22727647.
      Citations:    
    18. Priest ND, Hoel D. Determining the relative toxicity and RBE of internal emitters in animals. Health Phys. 2010 Sep; 99(3):367-70. PMID: 20699699.
      Citations:    
    19. Dauer LT, Brooks AL, Hoel DG, Morgan WF, Stram D, Tran P. Review and evaluation of updated research on the health effects associated with low-dose ionising radiation. Radiat Prot Dosimetry. 2010 Jul; 140(2):103-36. PMID: 20413418.
      Citations:    
    20. Priest ND, Hoel DG, Brooks PN. Relative toxicity of (45)Ca beta-particles and (242)Cm alpha-particles following their intravenous injection into mice as radiolabelled FAP. Int J Radiat Biol. 2010 Apr; 86(4):300-20. PMID: 20353340.
      Citations:    
    21. Svendsen ER, Kolpakov IE, Stepanova YI, Vdovenko VY, Naboka MV, Mousseau TA, Mohr LC, Hoel DG, Karmaus WJ. 137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident. Environ Health Perspect. 2010 May; 118(5):720-5. PMID: 20100677.
      Citations:    
    22. Wilson DA, Mohr LC, Frey GD, Lackland D, Hoel DG. Lung, liver and bone cancer mortality after plutonium exposure in beagle dogs and nuclear workers. Health Phys. 2010 Jan; 98(1):42-52. PMID: 19959950.
      Citations:    
    23. Wilson DA, Diel JH, Hoel DG. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2. Health Phys. 2009 Apr; 96(4):493-503. PMID: 19280755.
      Citations:    
    24. Jollow DJ, Bruckner JV, McMillan DC, Fisher JW, Hoel DG, Mohr LC. Trichloroethylene risk assessment: a review and commentary. Crit Rev Toxicol. 2009; 39(9):782-97. PMID: 19852561.
      Citations:    
    25. McGreevy KM, Lipsitz SR, Linder JA, Rimm E, Hoel DG. Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data. Clin Chem. 2009 Jan; 55(1):165-9. PMID: 19028825.
      Citations:    
    26. Baker PJ, Hoel DG. Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities. Eur J Cancer Care (Engl). 2007 Jul; 16(4):355-63. PMID: 17587361.
      Citations:    
    27. Adelman AS, Groves FD, O'Rourke K, Sinha D, Hulsey TC, Lawson AB, Wartenberg D, Hoel DG. Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study. Br J Cancer. 2007 Jul 02; 97(1):140-4. PMID: 17533404.
      Citations:    
    28. Reiss R, Anderson EL, Cross CE, Hidy G, Hoel D, McClellan R, Moolgavkar S. Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air. Inhal Toxicol. 2007 May; 19(5):419-49. PMID: 17365047.
      Citations:    
    29. McGreevy KM, Hoel BD, Lipsitz SR, Hoel DG. Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr. 2007 Jan; 10(1):97-105. PMID: 17212848.
      Citations:    
    30. Priest ND, Hoel DG, Brooks PN. Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice. Radiat Res. 2006 Nov; 166(5):782-93. PMID: 17067209.
      Citations:    
    31. Hoel DG. Ionizing radiation and cardiovascular disease. Ann N Y Acad Sci. 2006 Sep; 1076:309-17. PMID: 17119211.
      Citations:    
    32. Bronley-DeLancey A, McMillan DC, McMillan JM, Jollow DJ, Mohr LC, Hoel DG. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42. PMID: 16882532.
      Citations:    
    33. McGreevy K, Rodgers K, Lipsitz S, Bissada N, Hoel D. Impact of race and baseline PSA on longitudinal PSA. Int J Cancer. 2006 Apr 01; 118(7):1773-6. PMID: 16231314.
      Citations:    
    34. Makie T, Adcock D, Lackland DT, Hoel DG. Pulmonary abnormalities associated with occupational exposures at the Savannah River Site. Am J Ind Med. 2005 Nov; 48(5):365-72. PMID: 16254950.
      Citations:    
    35. McGreevy K, Hoel B, Lipsitz S, Bissada N, Hoel D. Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3. Urology. 2005 Sep; 66(3):587-92. PMID: 16140083.
      Citations:    
    36. Starr TB, Goodman JI, Hoel DG. Uses of benchmark dose methodology in quantitative risk assessment. Regul Toxicol Pharmacol. 2005 Jun; 42(1):1-2. PMID: 15896437.
      Citations:    
    37. Heath CW, Bond PD, Hoel DG, Meinhold CB. Residential radon exposure and lung cancer risk: commentary on Cohen's county-based study. Health Phys. 2004 Dec; 87(6):647-55; discussion 656-8. PMID: 15545771.
      Citations:    
    38. Baker GS, Hoel DG. Corrections in the atomic bomb data to examine low dose risk. Health Phys. 2003 Dec; 85(6):709-20. PMID: 14626322.
      Citations:    
    39. Creasman WT, Hoel D, Disaia PJ. WHI: Now that the dust has settled: a commentary. Am J Obstet Gynecol. 2003 Sep; 189(3):621-6. PMID: 14526278.
      Citations:    
    40. Nicholas JS, Butler GC, Davis S, Bryant E, Hoel DG, Mohr LC. Stable chromosome aberrations and ionizing radiation in airline pilots. Aviat Space Environ Med. 2003 Sep; 74(9):953-6. PMID: 14503673.
      Citations:    
    41. Carnes BA, Grahn D, Hoel D. Mortality of atomic bomb survivors predicted from laboratory animals. Radiat Res. 2003 Aug; 160(2):159-67. PMID: 12859226.
      Citations:    
    42. McGreevy KM, Baron LF, Hoel DG. Clinical breast examination practices among women undergoing screening mammography. Radiology. 2002 Aug; 224(2):555-9. PMID: 12147856.
      Citations:    
    43. Schubauer-Berigan MK, Baron L, Frey GD, Hoel DG. Breast dose variability in a bi-racial population undergoing screening mammography. Radiat Prot Dosimetry. 2002; 98(4):417-24. PMID: 12120669.
      Citations:    
    44. Schubauer-Berigan MK, Frey GD, Baron L, Hoel DG. Mammography dose in relation to body mass index, race, and menopausal status. Radiat Prot Dosimetry. 2002; 98(4):425-32. PMID: 12120670.
      Citations:    
    45. Nicholas JS, Butler GC, Lackland DT, Tessier GS, Mohr LC, Hoel DG. Health among commercial airline pilots. Aviat Space Environ Med. 2001 Sep; 72(9):821-6. PMID: 11565817.
      Citations:    
    46. Nicholas JS, Butler GC, Lackland DT, Hood WC, Hoel DG, Mohr LC. Flight deck magnetic fields in commercial aircraft. Am J Ind Med. 2000 Nov; 38(5):548-54. PMID: 11025496.
      Citations:    
    47. Radivoyevitch T, Hoel DG. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia. Radiat Environ Biophys. 2000 Sep; 39(3):153-9. PMID: 11095145.
      Citations:    
    48. Radivoyevitch T, Hoel DG. Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data. Math Biosci. 1999 Nov-Dec; 162(1-2):85-101. PMID: 10616282.
      Citations:    
    49. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 18494541.
      Citations:    
    50. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 10503702.
      Citations:    
    51. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 9421154.
      Citations:    
    52. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 1870606.
      Citations:    
    53. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 20508734.
      Citations:    
    54. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: practical considerations. Arch Surg. 1999 Jul; 134(7):764-7. PMID: 2792038.
      Citations:    
    55. Dinse GE, Umbach DM, Sasco AJ, Hoel DG, Davis DL. Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators? Annu Rev Public Health. 1999; 20:173-209. PMID: 10352856.
      Citations:    
    56. Nicholas JS, Lackland DT, Butler GC, Mohr LC, Dunbar JB, Kaune WT, Grosche B, Hoel DG. Cosmic radiation and magnetic field exposure to airline flight crews. Am J Ind Med. 1998 Dec; 34(6):574-80. PMID: 9816415.
      Citations:    
    57. Nicholas JS, Lackland DT, Dosemeci M, Mohr LC, Dunbar JB, Grosche B, Hoel DG. Mortality among US commercial pilots and navigators. J Occup Environ Med. 1998 Nov; 40(11):980-5. PMID: 9830605.
      Citations:    
    58. Hoel DG, Li P. Threshold models in radiation carcinogenesis. Health Phys. 1998 Sep; 75(3):241-50. PMID: 9721832.
      Citations:    
    59. Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8. PMID: 9627022.
      Citations:    
    60. Radivoyevitch T, Hoel DG, Hahnfeldt P, Sachs RK. Size distributions of misrejoining DNA fragments in irradiated cells. Math Biosci. 1998 May; 149(2):107-36. PMID: 9621680.
      Citations:    
    61. Radivoyevitch T, Hoel DG, Chen AM, Sachs RK. Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model. Radiat Res. 1998 Jan; 149(1):59-67. PMID: 9421155.
      Citations:    
    62. O'Brien ME, Hoel D. Overpowering pain. A serious problem comes out of the closet. Postgrad Med. 1997 Jul; 102(1):198-200, 205-7, 212. PMID: 9224487.
      Citations:    
    63. Hoel DG. Ionizing radiation and cancer prevention. Environ Health Perspect. 1995 Nov; 103 Suppl 8:241-3. PMID: 8741791.
      Citations:    
    64. Davis DL, Dinse GE, Hoel DG. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. Good news and bad news. JAMA. 1994 Feb 09; 271(6):431-7. PMID: 8295317.
      Citations:    
    65. Mori H, Nakamura T, Mine M, Kondo H, Okumura Y, Hoel DG. Early mortality rate of atomic bomb survivors based on House Reconstruction Survey. Int J Radiat Biol. 1994 Feb; 65(2):267-75. PMID: 7907124.
      Citations:    
    66. Hoel DG, Portier CJ. Nonlinearity of dose-response functions for carcinogenicity. Environ Health Perspect. 1994 Jan; 102 Suppl 1:109-13. PMID: 8187698.
      Citations:    
    67. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct; 101(5):372-7. PMID: 8119245.
      Citations:    
    68. Hoel DG. Questions about radiation and risk estimates that remain after BEIR V. Radiat Res. 1993 Oct; 136(1):137-9. PMID: 8210330.
      Citations:    
    69. Hoel DG, Ron E, Carter R, Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst. 1993 Jul 07; 85(13):1063-8. PMID: 8515493.
      Citations:    
    70. Fung VA, Huff J, Weisburger EK, Hoel DG. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam Appl Toxicol. 1993 May; 20(4):413-36. PMID: 8314458.
      Citations:    
    71. Davis DL, Blair A, Hoel DG. Agricultural exposures and cancer trends in developed countries. Environ Health Perspect. 1993 Apr; 100:39-44. PMID: 8354180.
      Citations:    
    72. Portier C, Tritscher A, Kohn M, Sewall C, Clark G, Edler L, Hoel D, Lucier G. Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. Fundam Appl Toxicol. 1993 Jan; 20(1):48-56. PMID: 8381755.
      Citations:    
    73. Davis DL, Hoel DG. Tobacco-associated deaths. Lancet. 1992 Sep 12; 340(8820):666. PMID: 1355221.
      Citations:    
    74. Dinse GE, Hoel DG. Exploring time trends in cancer incidence. Cancer Causes Control. 1992 Sep; 3(5):409-17. PMID: 1525321.
      Citations:    
    75. Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res. 1992 May; 130(2):249-66. PMID: 1574582.
      Citations:    
    76. Lucier GW, Thompson CL, Hoel DG. Omeprazole, cytochrome P450, and chemical carcinogenesis. Gastroenterology. 1992 May; 102(5):1823-4. PMID: 1314754.
      Citations:    
    77. Hoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst. 1992 Mar 04; 84(5):313-20. PMID: 1738181.
      Citations:    
    78. Piegorsch WW, Carr GJ, Portier CJ, Hoel DG. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation. Risk Anal. 1992 Mar; 12(1):115-21. PMID: 1574611.
      Citations:    
    79. Davis DL, Hoel DG. Figuring out cancer. Int J Health Serv. 1992; 22(3):447-53. PMID: 1644508.
      Citations:    
    80. Huff J, Hoel D. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992; 18 Suppl 1:83-9. PMID: 1411384.
      Citations:    
    81. Swenberg JA, Hoel DG, Magee PN. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res. 1991 Dec 01; 51(23 Pt 2):6409-14. PMID: 1933905.
      Citations:    
    82. Hoel DG. A balanced approach to risk assessment. Toxicol Ind Health. 1991 Sep-Nov; 7(5-6):305-11. PMID: 1780871.
      Citations:    
    83. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med. 1991; 19(4):421-31. PMID: 2035544.
      Citations:    
    84. Hoel DG. Assumptions of the HERP Index. Risk Anal. 1990 Dec; 10(4):623-4; discussion 629-33. PMID: 2287788.
      Citations:    
    85. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet. 1990 Aug 25; 336(8713):474-81. PMID: 1974997.
      Citations:    
    86. Hoel DG, Dinse GE. Using mortality data to estimate radiation effects on breast cancer incidence. Environ Health Perspect. 1990 Jul; 87:123-9. PMID: 2269215.
      Citations:    
    87. Portier CJ, Hoel DG, Kaplan NL, Kopp A. Biologically based models for risk assessment. IARC Sci Publ. 1990; (104):20-8. PMID: 2228117.
      Citations:    
    88. Davis DL, Hoel D, Percy C, Ahlbom A, Schwartz J. Is brain cancer mortality increasing in industrial countries? Ann N Y Acad Sci. 1990; 609:191-204. PMID: 2264643.
      Citations:    
    89. Davis DL, Hoel D, Fox J, Lopez AD. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci. 1990; 609:5-48. PMID: 2264657.
      Citations:    
    90. Davis DL, Hoel D. Trends in cancer mortality in industrial countries. Introduction. Ann N Y Acad Sci. 1990; 609:ix-xi. PMID: 2264635.
      Citations:    
    91. Bailer AJ, Hoel DG. Benzene risk assessments: review and update. Cell Biol Toxicol. 1989 Nov; 5(3):287-95. PMID: 2688843.
      Citations:    
    92. Hoel DG, Haseman JK, Hogan MD, Huff J, McConnell EE. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52. PMID: 3052903.
      Citations:    
    93. Piegorsch WW, Hoel DG. Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75. PMID: 3419441.
      Citations:    
    94. Pedersen LG, Darden TA, Deerfield DW, Anderson MW, Hoel DG. A theoretical study of the effect of methylation or ethylation at O6-guanine in the structure and energy of DNA double strands. Carcinogenesis. 1988 Sep; 9(9):1553-62. PMID: 3409460.
      Citations:    
    95. Hoel DG. Cancer risk models for ionizing radiation. Environ Health Perspect. 1987 Dec; 76:121-4. PMID: 3447889.
      Citations:    
    96. Portier CJ, Hoel DG. Issues concerning the estimation of the TD50. Risk Anal. 1987 Dec; 7(4):437-47. PMID: 3444931.
      Citations:    
    97. Weinberg CR, Brown KG, Hoel DG. Altitude, radiation, and mortality from cancer and heart disease. Radiat Res. 1987 Nov; 112(2):381-90. PMID: 3685264.
      Citations:    
    98. Hoel DG. Radiation risk estimation models. Environ Health Perspect. 1987 Nov; 75:105-7. PMID: 3319558.
      Citations:    
    99. Portier CJ, Hedges JC, Hoel DG. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 1986 Sep; 46(9):4372-8. PMID: 3731095.
      Citations:    
    100. Brown KG, Hoel DG. Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. Risk Anal. 1986 Jun; 6(2):155-66. PMID: 3615985.
      Citations:    
    101. Gold LS, Bernstein L, Kaldor J, Backman G, Hoel D. An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol. 1986 Feb; 6(2):263-9. PMID: 3699316.
      Citations:    
    102. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Toxicity and carcinogenic potency. Risk Anal. 1985 Dec; 5(4):263-4. PMID: 3843685.
      Citations:    
    103. Yanagawa T, Hoel DG. Use of historical controls for animal experiments. Environ Health Perspect. 1985 Nov; 63:217-24. PMID: 4076086.
      Citations:    
    104. Hoel DG. Epidemiology and the inference of cancer mechanisms. Natl Cancer Inst Monogr. 1985 May; 67:199-203. PMID: 4047148.
      Citations:    
    105. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb; 5(1):79-86. PMID: 3987994.
      Citations:    
    106. Racine-Poon AH, Hoel DG. Nonparametric estimation of the survival function when cause of death is uncertain. Biometrics. 1984 Dec; 40(4):1151-8. PMID: 6534414.
      Citations:    
    107. Portier CJ, Hoel DG. Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam Appl Toxicol. 1984 Dec; 4(6):949-59. PMID: 6519375.
      Citations:    
    108. Portier C, Hoel D. Low-dose-rate extrapolation using the multistage model. Biometrics. 1983 Dec; 39(4):897-906. PMID: 6671125.
      Citations:    
    109. Brown KG, Hoel DG. Multistage prediction of cancer in serially dosed animals with application to the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):470-7. PMID: 6642104.
      Citations:    
    110. Brown KG, Hoel DG. Modeling time-to-tumor data: analysis of the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):458-69. PMID: 6642103.
      Citations:    
    111. Hoel DG, Wakabayashi T, Pike MC. Secular trends in the distributions of the breast cancer risk factors--menarche, first birth, menopause, and weight--in Hiroshima and Nagasaki, Japan. Am J Epidemiol. 1983 Jul; 118(1):78-89. PMID: 6869366.
      Citations:    
    112. Portier C, Hoel D. Optimal design of the chronic animal bioassay. J Toxicol Environ Health. 1983 Jul; 12(1):1-19. PMID: 6631999.
      Citations:    
    113. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983 Jun 30; 303(5920):767-70. PMID: 6866078.
      Citations:    
    114. Hoel DG, Kaplan NL, Anderson MW. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 04; 219(4588):1032-7. PMID: 6823565.
      Citations:    
    115. Hoel DG. Carcinogens in the workplace. Science. 1982 Nov 05; 218(4572):560-1. PMID: 17842056.
      Citations:    
    116. Kato H, Brown CC, Hoel DG, Schull WJ. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants. Radiat Res. 1982 Aug; 91(2):243-64. PMID: 7100400.
      Citations:    
    117. Hoel DG. Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38. PMID: 6754310.
      Citations:    
    118. Haseman JK, Hoel DG, Jennrich RI. Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep; 8(3):379-86. PMID: 6808148.
      Citations:    
    119. Anderson MW, Hoel DG, Kaplan NL. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. Toxicol Appl Pharmacol. 1980 Aug; 55(1):154-61. PMID: 7423500.
      Citations:    
    120. Hoel DG. Incorporation of background in dose-response models. Fed Proc. 1980 Jan; 39(1):73-5. PMID: 7351247.
      Citations:    
    121. Hoel DG. Animal experimentation and its relevance to man. Environ Health Perspect. 1979 Oct; 32:25-30. PMID: 540597.
      Citations:    
    122. Hoel DG. Statistical approaches to toxicological data. Environ Health Perspect. 1979 Oct; 32:267-71. PMID: 540599.
      Citations:    
    123. Haseman JK, Hoel DG. Statistical design of toxicity assays: role of genetic structure of test animal population. J Environ Pathol Toxicol. 1979 Jul-Aug; 2(6):1313-27. PMID: 528844.
      Citations:    
    124. Hoel DG. Sequential methods in genetic risk assessment. Genetics. 1979 May; 92(1 Pt 1 Suppl):s195-8. PMID: 488701.
      Citations:    
    125. Haseman JK, Hoel DG. Statistical design of toxicity assays: role of genetic structure of test animal population. J Toxicol Environ Health. 1979 Jan; 5(1):89-101. PMID: 423309.
      Citations:    
    126. Hogan MD, Chi PY, Hoel DG, Mitchell TJ. Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J Environ Pathol Toxicol. 1979 Jan-Feb; 2(3):873-87. PMID: 422940.
      Citations:    
    127. Guess HA, Hoel DG. The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86. PMID: 553134.
      Citations:    
    128. Hoel DG. Biometry branch: summary statement. Environ Health Perspect. 1977 Oct; 20:217-9. PMID: 17539129.
      Citations:    
    129. Crump KS, Hoel DG, Langley CH, Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 1976 Sep; 36(9 pt.1):2973-9. PMID: 975067.
      Citations:    
    130. Hoel DG. Occupational carcinogenesis. Statistical extrapolation methods for estimating risks from animal data. Ann N Y Acad Sci. 1976; 271:418-20. PMID: 1069534.
      Citations:    
    131. Hoel DG, Gaylor DW, Kirschstein RL, Saffiotti U, Schneiderman MA. Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep; 1(1):133-51. PMID: 810599.
      Citations:    
    132. Hoel DG, Crump KS. Estimating the generation-time distribution of an age-dependent branching process. Biometrics. 1974 Mar; 30(1):125-35. PMID: 4813378.
      Citations:    
    133. Hoel DG, Walburg HE. Statistical analysis of survival experiments. J Natl Cancer Inst. 1972 Aug; 49(2):361-72. PMID: 5076821.
      Citations:    
    134. Hoel DG. A representation of mortality data by competing risks. Biometrics. 1972 Jun; 28(2):475-88. PMID: 4556703.
      Citations:    
    135. Hoel DG, Mitchell TJ. The simulation, fitting, and testing of a stochastic cellular proliferation model. Biometrics. 1971 Mar; 27(1):191-9. PMID: 4926451.
      Citations:    
    136. Kenney F, Lee KL, Reel JR, Hoel DG. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. IX. Studies of the mechanisms of hormonal inductions in cultured hepatoma cells. J Biol Chem. 1970 Nov 10; 245(21):5806-12. PMID: 4394357.
      Citations:    
    Hoel's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (429)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _